Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

IFRX InflaRx NV

1,64

0,19 (13,10%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more InflaRx NV Charts.

InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more InflaRx NV Charts.

News InflaRx NV

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 8 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
Mittwoch 8 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
Dienstag 30 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
Mittwoch 24 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
Dienstag 19 März 2024 (2 Monate vor) • GlobeNewswire Inc.

InflaRx Appoints Jan Medina as Head of Investor Relations
Donnerstag 22 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 25 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
Donnerstag 25 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 4 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
Donnerstag 4 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 6 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere InflaRx NV News-Artikel

Mass Vehicle Ledger Token

Gauntlet Finance

Hillman Solutions

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen